WTF?
'This partnership will rely on Bio-Sourcing’s BioMilk platform, which uses genome editing to produce monoclonal antibodies (mAbs) in transgenic goats’ milk. Currently, South Africa imports biotherapeutics, but Bio-Sourcing and Afrigen are planning a pilot program with hopes of later commercial-scale production of mAbs.'
